Regenity Biosciences
Regenity Biosciences, a global leader in regenerative medicine, is honored to be recognized as a winner of the prestigious 2025 R&D 100 Award—regarded across industry as the “Oscars of Innovation”—for RejuvaKnee™, the only available FDA-cleared meniscal implant designed for reinforcement and repair of the medial meniscus. RejuvaKnee™ provides a bioabsorbable scaffold that supports the natural regeneration of the patient’s own native meniscus, which may help restore the natural biomechanics of...
Private Company
Total funding raised: $15M
About
Regenity Biosciences, a global leader in regenerative medicine, is honored to be recognized as a winner of the prestigious 2025 R&D 100 Award—regarded across industry as the “Oscars of Innovation”—for RejuvaKnee™, the only available FDA-cleared meniscal implant designed for reinforcement and repair of the medial meniscus. RejuvaKnee™ provides a bioabsorbable scaffold that supports the natural regeneration of the patient’s own native meniscus, which may help restore the natural biomechanics of...